In vivo fitness of carbapenem-resistant Acinetobacter baumannii strains in murine infection is associated with treatment failure in human infections
Authors:
- 1 January 2022
- journal article
- research article
- Published by Elsevier in Clinical Microbiology and Infection
- Vol. 28 (1) , 73-78
Abstract
No abstract availableKeywords
Funding Information
- Seventh Framework Programme (F3-2011-278348)
- European Commission
This publication has 25 references indexed in Scilit:
- Carbapenem resistance and mortality in patients with Acinetobacter baumannii infection: systematic review and meta-analysisClinical Microbiology and Infection, 2014
- The Success of Acinetobacter Species; Genetic, Metabolic and Virulence AttributesPLOS ONE, 2012
- Risk factors and clinical outcomes of patients with carbapenem-resistant Acinetobacter baumannii bacteremiaJournal of Microbiology, Immunology and Infection, 2012
- Role of Acinetobactin-Mediated Iron Acquisition Functions in the Interaction of Acinetobacter baumannii Strain ATCC 19606 T with Human Lung Epithelial Cells, Galleria mellonella Caterpillars, and MiceInfection and Immunity, 2012
- Inactivation of Phospholipase D DiminishesAcinetobacter baumanniiPathogenesisInfection and Immunity, 2010
- Methods to Determine Fitness in Bacteria2010
- Acinetobacter baumannii : Emergence of a Successful PathogenClinical Microbiology Reviews, 2008
- Attributable mortality of Acinetobacter baumannii: no longer a controversial issueCritical Care, 2007
- Identification of Acinetobacter baumannii by Detection of the bla OXA-51-like Carbapenemase Gene Intrinsic to This SpeciesJournal of Clinical Microbiology, 2006
- In vitro and in vivo activity of meropenem and sulbactam against a multidrug-resistant Acinetobacter baumannii strainJournal of Antimicrobial Chemotherapy, 2004